Capabilities to build a “bank” for stem cells derived from umbilical cord blood (socalled
“cord blood”) which can be used for many clinical applications in regenerative medicine and
tissue engineering. Providing GMP and regulatory support for processing, development and
commercialization of cordderived stem cells, biologics and combinational products.

Highlights

Spin Out Companies

Benefiting Companies

Center's University Website and Contact Information